[1]
|
Heidenreich, P.A., Bozkurt, B., Aguilar, D., et al. (2022) 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation, 145, e876-e894.
https://doi.org/10.1161/CIR.0000000000001062
|
[2]
|
Orso, F., Fabbri, G. and Maggioni, A.P. (2017) Epidemiol-ogy of Heart Failure. In: Bauersachs, J., Butler, J. and Sandner, P., Eds., Heart Failure, Handbook of Experimental Pharmacology, Vol. 243, Springer, Berlin, 15-33.
https://doi.org/10.1007/164_2016_74
|
[3]
|
Emmons-Bell, S., Johnson, C. and Roth, G. (2022) Prevalence, Inci-dence and Survival of Heart Failure: A Systematic Review. Heart (British Cardiac Society), 108, 1351-1360. https://doi.org/10.1136/heartjnl-2021-320131
|
[4]
|
Rushton, S., Parameshwar, J., Lim, S., et al. (2020) The Intro-duction of a Super-Urgent Heart Allocation Scheme in the UK: A 2-Year Review. The Journal of Heart and Lung Transplantation: The Official Publication of the International Society for Heart Transplantation, 39, 1109-1117. https://doi.org/10.1016/j.healun.2020.06.013
|
[5]
|
Hosenpud, J.D., Bennett, L.E., Keck, B.M., et al. (2000) The Registry of the International Society for Heart and Lung Transplantation: Seventeenth Official Report-2000. The Journal of Heart and Lung Transplantation: The Official Publication of the International Society for Heart Transplantation, 19, 909-931.
https://doi.org/10.1016/S1053-2498(00)00138-8
|
[6]
|
Chang, P.P., Longenecker, J.C., Wang, N.Y., et al. (2005) Mild vs Severe Pulmonary Hypertension before Heart Transplantation: Different Effects on Posttransplantation Pulmo-nary Hypertension and Mortality. The Journal of Heart and Lung Transplantation: The Official Publication of the Inter-national Society for Heart Transplantation, 24, 998-1007.
https://doi.org/10.1016/j.healun.2004.07.013
|
[7]
|
Vakil, K., Duval, S., Sharma, A., et al. (2014) Impact of Pre-Transplant Pulmonary Hypertension on Survival after Heart Transplantation: A UNOS Registry Analysis. Interna-tional Journal of Cardiology, 176, 595-599.
https://doi.org/10.1016/j.ijcard.2014.08.072
|
[8]
|
Russ, M., Steiner, E., Boemke, W., et al. (2022) Extracorporeal Membrane Oxygenation Blood Flow and Blood Recirculation Compromise Thermodilution-Based Measurements of Cardiac Output. ASAIO Journal (American Society for Artificial Internal Organs: 1992), 68, 721-729. https://doi.org/10.1097/MAT.0000000000001592
|
[9]
|
黄洁, 李飞. 中国心脏移植受者术前评估与准备技术规范(2019版) [J]. 中华移植杂志(电子版), 2019, 13(1): 1-7.
|
[10]
|
Tseliou, E., Lavine, K.J., Wever-Pinzon, O., et al. (2022) Biology of Myocardial Recovery in Advanced Heart Failure with Long-Term Mechanical Support. The Journal of Heart and Lung Transplantation: The Official Publication of the International Society for Heart Transplantation, 41, 1309-1323. https://doi.org/10.1016/j.healun.2022.07.007
|
[11]
|
Mikus, E., Stepanenko, A., Krabatsch, T., et al. (2011) Left Ventricular Assist Device or Heart Transplantation: Impact of Transpulmonary Gradient and Pulmonary Vascular Resistance on Decision Making. European Journal of Cardio-Thoracic Surgery: Official Journal of the Euro-pean Association for Cardio-Thoracic Surgery, 39, 310-316.
https://doi.org/10.1016/j.ejcts.2010.05.031
|
[12]
|
Goland, S., Czer, L.S., Kass, R.M., et al. (2007) Pre-Existing Pulmonary Hypertension in Patients with End-Stage Heart Failure: Impact on Clinical Outcome and Hemodynamic Fol-low-Up after Orthotopic Heart Transplantation. The Journal of Heart and Lung Transplantation: The Official Publication of the International Society for Heart Transplantation, 26, 312-318. https://doi.org/10.1016/j.healun.2006.12.012
|
[13]
|
Perez Ruiz de Garibay, A., Kortgen, A., Leonhardt, J., et al. (2022) Critical Care Hepatology: Definitions, Incidence, Prognosis and Role of Liver Failure in Critically Ill Patients. Critical Care (London, England), 26, Article No. 289.
https://doi.org/10.1186/s13054-022-04163-1
|
[14]
|
Vinsonneau, C., Camus, C., Combes, A., et al. (2006) Continuous Venovenous Haemodiafiltration versus Intermittent Haemodialysis for Acute Renal Failure in Patients with Multiple-Organ Dysfunction Syndrome: A Multicentre Randomised trial. The Lancet (London, England), 368, 379-385. https://doi.org/10.1016/S0140-6736(06)69111-3
|
[15]
|
Jenniskens, M., Langouche, L., Vanwijngaerden, Y.M., et al. (2016) Cholestatic Liver (Dys)function during Sepsis and Other Critical Illnesses. Intensive Care Medicine, 42, 16-27. https://doi.org/10.1007/s00134-015-4054-0
|
[16]
|
Watchko, J.F. and Tiribelli, C. (2013) Bilirubin-Induced Neuro-logic Damage—Mechanisms and Management Approaches. The New England Journal of Medicine, 369, 2021-2030. https://doi.org/10.1056/NEJMra1308124
|
[17]
|
Montoya, J.G., Giraldo, L.F., Efron, B., et al. (2001) Infectious Complications among 620 Consecutive Heart Transplant Patients at Stanford University Medical Center. Clinical Infec-tious Diseases: An Official Publication of the Infectious Diseases Society of America, 33, 629-640. https://doi.org/10.1086/322733
|
[18]
|
Horcajada, J.P., Montero, M., Oliver, A., et al. (2019) Epidemiology and Treatment of Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa Infections. Clinical Micro-biology Reviews, 32, e00031-19.
https://doi.org/10.1128/CMR.00031-19
|
[19]
|
Vanscoy, B.D., Mendes, R.E., Castanheira, M., et al. (2014) Rela-tionship between Ceftolozane-Tazobactam Exposure and Selection for Pseudomonas aeruginosa Resistance in a Hol-low-Fiber Infection Model. Antimicrobial Agents and Chemotherapy, 58, 6024-6031. https://doi.org/10.1128/AAC.02310-13
|
[20]
|
Ribera, A., Benavent, E., Lora-Tamayo, J., et al. (2015) Osteoarticular Infection Caused by MDR Pseudomonas aeruginosa: The Benefits of Combination Therapy with Colistin plus β-Lactams. The Journal of Antimicrobial Chemotherapy, 70, 3357-3365. https://doi.org/10.1093/jac/dkv281
|
[21]
|
Lin, Y.W., Zhou, Q., Onufrak, N.J., et al. (2017) Aerosolized Polymyxin B for Treatment of Respiratory Tract Infections: Determination of Pharmacokinetic-Pharmacodynamic Indices for Aero-solized Polymyxin B against Pseudomonas aeruginosa in a Mouse Lung Infection Model. Antimicrobial Agents and Chemotherapy, 61, e00211-17.
https://doi.org/10.1128/AAC.00211-17
|
[22]
|
Pereira, G.H., Muller, P.R. and Levin, A.S. (2007) Salvage Treatment of Pneumonia and Initial Treatment of Tracheobronchitis Caused by Multidrug-Resistant Gram-Negative Bacilli with In-haled Polymyxin B. Diagnostic Microbiology and Infectious Disease, 58, 235-240. https://doi.org/10.1016/j.diagmicrobio.2007.01.008
|
[23]
|
Korkmaz Ekren, P., Toreyin, N., Sayiner, A., et al. (2016) The Role of Aerolized Colistin in the Treatment of Hospital-Acquired Pneumonia: Experience of Multicenter from Turkey. Critical Care Medicine, 44, e304.
https://doi.org/10.1097/CCM.0000000000001539
|